£64.81

Springer Serotonin: ein funktioneller Ansatz für die psychiatrische Diagnose und Therapie? (duphar med communication)

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 7 months ago.

£65 today · all-time low £62 (Nov 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 301 days • 301 data points (No recent data available)

Historical
Generating forecast...
£64.86 £61.67 £62.37 £63.06 £63.76 £64.45 £65.15 01 May 2025 15 July 2025 28 September 2025 12 December 2025 25 February 2026

Price Distribution

Price distribution over 301 days • 2 price levels

Days at Price
Current Price
50 days 251 days · current 0 63 126 188 251 £62 £65 Days at Price

Price Analysis

Most common price: £65 (251 days, 83.4%)

Price range: £62 - £65

Price levels: 2 different prices over 301 days

Description

In den letzten vier Jahrzehnten hat sich in der Psychiatrie emlges bewegt: Die Neurobiologie hat in der psychiatrischen Grundlagenfor schung und fur die Behandlung psychiatrischer Krankheiten immer grof3eres Gewicht bekommen! In wechselseitiger Befruchtung von neurobiologischer Forschung und klinischer Beobachtung wurden operation ale Klassifikationssy sterne fur psychiatrische Krankheiten und neue MeBmethoden zur standardisierten Erfassung psychischer StOrungen entwickelt. Diese method is chen Fortschritte kamen vor aHem auch der Therapiefor schung zugute. Die Psychiatrie und die psychiatrischen Behandlungs verfahren wurden wieder Gegenstand empirischer Forschung! Bei endogenen Depressionen muBten sich die Psychiater bis zur Mitte der 30er Jahre unseres Jahrhunderts - bis zur Einfuhrung der Elektrokrampftherapie - darauf beschranken, das subjektive Leiden ihrer Patienten zu begleiten; in diesem Zusammenhang war es auch damals schon wichtig, bei depressiven Kranken das Suizidrisiko zu erkennen und - wenn ni:itig - unter stationaren Bedingungen zu ver ringern. Etwa 20 Jahre spater (1957) wurden durch klinische Beobachtungen die antidepressiven Wirkungen von Medikamenten entdeckt. Imipra min, das erste trizyklische Antidepressivum, und der Monoaminoxy dasehemmer Iproniazid wurden in die psychiatrische Therapie einge fuhrt. In der Folgezeit wurden viele neue Antidepressiva entwickelt: Zu den Trizyklika kamen spater die Tetrazyklika und weitere MAO Hemmer. Ende der 70er Jahre wurden die Serotonin-Wiederaufnah mehemmer als neue Gruppe der Antidepressiva entdeckt. Den vorl au fig letzten Entwicklungsschritt steHt die neue Generation der reversi bIen MAO-Hemmer dar.

Product Specifications

Format
Paperback
Domain
Amazon UK
Publication Date
09 January 1992
Listed Since
08 August 2012

Barcode

No barcode data available

Similar Products You Might Like

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)
96% match

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Springer

£294.92 12 Jan 2026
Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)
96% match

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Springer

£180.00 06 Jan 2026
Differenzierte Therapie mit trizyklischen Antidepressiva
96% match

Differenzierte Therapie mit trizyklischen Antidepressiva

Springer

£46.75 28 Feb 2026
Pharmacotherapy of Depression
95% match

Pharmacotherapy of Depression

Humana

£79.93 23 Feb 2026
Neuro-Psychopharmaka Ein Therapie-Handbuch: Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer
95% match

Neuro-Psychopharmaka Ein Therapie-Handbuch: Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer

Springer

£128.12 13 Mar 2026
Prescriber's Guide: Antidepressants: Stahl's Essential Psychopharmacology
95% match

Prescriber's Guide: Antidepressants: Stahl's Essential Psychopharmacology

Cambridge University Press

£55.69 13 Jan 2026
Antidepressants (Milestones in Drug Therapy)
95% match

Antidepressants (Milestones in Drug Therapy)

Birkhauser

£63.53 20 Feb 2026
Melatonin, Neuroprotective Agents and Antidepressant Therapy
95% match

Melatonin, Neuroprotective Agents and Antidepressant Therapy

Springer

£167.53 24 Jan 2026
Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest
95% match

Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest

MACMILLAN

£91.23 08 Jan 2026
Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)
95% match

Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)

Humana

£144.11 13 Jan 2026
Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)
95% match

Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)

Humana

£119.90 13 Jan 2026
Antidepressants: Types, Efficiency & Possible Side Effects (Depression-Causes, Diagnosis, and Treatment)
95% match

Antidepressants: Types, Efficiency & Possible Side Effects (Depression-Causes, Diagnosis, and Treatment)

£66.90 02 Mar 2026
Drugs in Psychiatry 2/e
95% match

Drugs in Psychiatry 2/e

Oxford University Press

£49.00 21 Feb 2026
Duloxetine: Clinical Uses, Mechanism of Action and Efficacy
95% match

Duloxetine: Clinical Uses, Mechanism of Action and Efficacy

£185.99 27 Jan 2026
The Myth of Depression as Disease: Limitations and Alternatives to Drug Treatment (Contemporary Psychology)
95% match

The Myth of Depression as Disease: Limitations and Alternatives to Drug Treatment (Contemporary Psychology)

By

£50.73 07 Mar 2026
Treatment-Resistant Mood Disorders
95% match

Treatment-Resistant Mood Disorders

Cambridge University Press

£57.15 24 Feb 2026
Serotonin: From Cell Biology to Pharmacology and Therapeutics: 5 (Medical Science Symposia Series, 5)
95% match

Serotonin: From Cell Biology to Pharmacology and Therapeutics: 5 (Medical Science Symposia Series, 5)

Springer

£105.66 17 Feb 2026
Pharmacotherapy of Child and Adolescent Psychiatric Disorders
95% match

Pharmacotherapy of Child and Adolescent Psychiatric Disorders

Wiley-Blackwell

£70.99 26 Feb 2026
The Pharmacogenetics of Antidepressant Response: Moving towards Individualized Therapy - Improving Patient Outcomes through Optimization of Treatment Based on Genetic Makeup
95% match

The Pharmacogenetics of Antidepressant Response: Moving towards Individualized Therapy - Improving Patient Outcomes through Optimization of Treatment Based on Genetic Makeup

VDM Verlag

£66.00 22 Feb 2026
Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression (Disease and Desire)
95% match

Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression (Disease and Desire)

NYU Press

£68.00 31 Jan 2026
Rapid Acting Antidepressants: Volume 89 (Advances in Pharmacology, Volume 89)
94% match

Rapid Acting Antidepressants: Volume 89 (Advances in Pharmacology, Volume 89)

Academic Press

£169.89 15 Feb 2026
The Rise and Fall of the Age of Psychopharmacology
94% match

The Rise and Fall of the Age of Psychopharmacology

Oxford University Press

£43.99 07 Mar 2026
Neurobiology of Depression: Road to Novel Therapeutics
94% match

Neurobiology of Depression: Road to Novel Therapeutics

Academic Press

£101.89 11 Feb 2026
Serotonin Receptors in Neurobiology (Frontiers in Neuroscience)
94% match

Serotonin Receptors in Neurobiology (Frontiers in Neuroscience)

CRC Press

£124.92 08 Mar 2026